Published in Cell on August 01, 1979
Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci U S A (1989) 7.19
A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J (1989) 6.37
Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol (1994) 5.93
Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest (1999) 5.30
Nuclear reprogramming to a pluripotent state by three approaches. Nature (2010) 5.26
Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genet (2007) 5.16
DNA methylation and gene expression. Microbiol Rev (1991) 4.44
Identification of a myocyte nuclear factor that binds to the muscle-specific enhancer of the mouse muscle creatine kinase gene. Mol Cell Biol (1989) 3.98
Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc Natl Acad Sci U S A (1995) 3.56
Myf-6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12. EMBO J (1990) 3.16
The muscle creatine kinase gene is regulated by multiple upstream elements, including a muscle-specific enhancer. Mol Cell Biol (1988) 3.11
5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal. Mol Cell Biol (2005) 3.05
Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products. EMBO J (1989) 2.88
Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone. J Cell Biol (1988) 2.73
Direct lineage conversions: unnatural but useful? Nat Biotechnol (2011) 2.69
Targeting DNA methylation. Clin Cancer Res (2009) 2.45
De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. Proc Natl Acad Sci U S A (1990) 2.42
Noncanonical Wnt signaling through G protein-linked PKCdelta activation promotes bone formation. Dev Cell (2007) 2.41
Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell (2014) 2.28
Expression of a cloned adenovirus gene is inhibited by in vitro methylation. Proc Natl Acad Sci U S A (1982) 2.23
Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol (1998) 2.17
MyoD expression in the forming somites is an early response to mesoderm induction in Xenopus embryos. EMBO J (1989) 2.16
5-Azacytidine and RNA secondary structure increase the retrovirus mutation rate. J Virol (1992) 2.03
DNA methylation affecting the expression of murine leukemia proviruses. J Virol (1982) 2.03
Induction of sarcomas by mutant IDH2. Genes Dev (2013) 2.02
The structure and expression of a novel gene activated in early mouse embryogenesis. EMBO J (1988) 1.98
Adipose tissue stem cells meet preadipocyte commitment: going back to the future. J Lipid Res (2011) 1.94
BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J Bone Miner Res (2006) 1.91
BMP signaling pathway is required for commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc Natl Acad Sci U S A (2009) 1.90
Cell cycle-specific reactivation of an inactive X-chromosome locus by 5-azadeoxycytidine. Proc Natl Acad Sci U S A (1982) 1.84
An estrogen-dependent demethylation at the 5' end of the chicken vitellogenin gene is independent of DNA synthesis. Nucleic Acids Res (1984) 1.83
Epigenetics as a mechanism driving polygenic clinical drug resistance. Br J Cancer (2006) 1.77
Expression of the chloramphenicol acetyltransferase gene in mammalian cells under the control of adenovirus type 12 promoters: effect of promoter methylation on gene expression. Proc Natl Acad Sci U S A (1983) 1.76
Complex regulation of the muscle-specific contractile protein (troponin I) gene. Mol Cell Biol (1987) 1.75
Molecular roadblocks for cellular reprogramming. Mol Cell (2012) 1.74
Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: role of the BMP-4 gene. Proc Natl Acad Sci U S A (2006) 1.70
Hemimethylated duplex DNAs prepared from 5-azacytidine-treated cells. Nucleic Acids Res (1981) 1.70
Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc Natl Acad Sci U S A (2006) 1.63
Targeting DNA methylation for epigenetic therapy. Trends Pharmacol Sci (2010) 1.61
Differentiation, not determination, regulates muscle gene activation: transfection of troponin I genes into multipotential and muscle lineages of 10T1/2 cells. Mol Cell Biol (1985) 1.59
In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J Bone Miner Res (2003) 1.57
MyoD and the regulation of myogenesis by helix-loop-helix proteins. J Clin Invest (1991) 1.52
10T1/2 cells: an in vitro model for molecular genetic analysis of mesodermal determination and differentiation. Environ Health Perspect (1989) 1.52
Leveling Waddington: the emergence of direct programming and the loss of cell fate hierarchies. Nat Rev Mol Cell Biol (2013) 1.52
Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes. Cancer (2011) 1.51
DNA methylation of three 5' C-C-G-G 3' sites in the promoter and 5' region inactivate the E2a gene of adenovirus type 2. Proc Natl Acad Sci U S A (1984) 1.50
A blueprint for engineering cell fate: current technologies to reprogram cell identity. Cell Res (2013) 1.50
Histone demethylase LSD1 regulates adipogenesis. J Biol Chem (2010) 1.50
Control of adipocyte differentiation. Biochem J (1995) 1.48
Phenotypic analysis of Meltrin alpha (ADAM12)-deficient mice: involvement of Meltrin alpha in adipogenesis and myogenesis. Mol Cell Biol (2003) 1.47
Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin. Proc Natl Acad Sci U S A (1984) 1.46
Myf5 is a direct target of long-range Shh signaling and Gli regulation for muscle specification. Genes Dev (2002) 1.46
Generation of hyaline cartilaginous tissue from mouse adult dermal fibroblast culture by defined factors. J Clin Invest (2011) 1.45
Weighing in on adipocyte precursors. Cell Metab (2013) 1.43
Pre-adipocyte determination either by insulin or by 5-azacytidine. Proc Natl Acad Sci U S A (1982) 1.42
Azacytidine-induced tumorigenesis of CHEF/18 cells: correlated DNA methylation and chromosome changes. Proc Natl Acad Sci U S A (1983) 1.41
Emerging role of bone morphogenetic proteins in adipogenesis and energy metabolism. Cytokine Growth Factor Rev (2009) 1.39
CDO, a robo-related cell surface protein that mediates myogenic differentiation. J Cell Biol (1998) 1.37
Hedgehog-Gli pathway activation during kidney fibrosis. Am J Pathol (2012) 1.34
Epigenetic regulation of protein tyrosine phosphatases: potential molecular targets for cancer therapy. Cancer Gene Ther (2005) 1.34
Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro. J Cell Biol (1999) 1.33
Expression of E1A in terminally differentiated muscle cells reactivates the cell cycle and suppresses tissue-specific genes by separable mechanisms. Mol Cell Biol (1996) 1.33
Emerging roles for the transforming growth factor-{beta} superfamily in regulating adiposity and energy expenditure. Endocr Rev (2010) 1.32
DNA methylation in 5-aza-2'-deoxycytidine-resistant variants of C3H 10T1/2 C18 cells. Mol Cell Biol (1984) 1.24
Adipogenesis. Cold Spring Harb Perspect Biol (2012) 1.23
High-frequency conversion to a "fluffy" developmental phenotype in Aspergillus spp. by 5-azacytidine treatment: evidence for involvement of a single nuclear gene. Mol Cell Biol (1983) 1.23
Wnt signaling and skeletal development. Cell Signal (2007) 1.22
Progressive increases in the methylation status and heterochromatinization of the myoD CpG island during oncogenic transformation. Mol Cell Biol (1994) 1.22
Heterodimers of myogenic helix-loop-helix regulatory factors and E12 bind a complex element governing myogenic induction of the avian cardiac alpha-actin promoter. Mol Cell Biol (1991) 1.22
Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways. Endocrinology (2008) 1.20
Phenotypic switching in cells transformed with the herpes simplex virus thymidine kinase gene. Mol Cell Biol (1982) 1.18
Oncogenic v-Abl tyrosine kinase can inhibit or stimulate growth, depending on the cell context. EMBO J (1992) 1.18
Overexpression of hTERT increases stem-like properties and decreases spontaneous differentiation in human mesenchymal stem cell lines. J Biomed Sci (2010) 1.16
Regulation of c-maf gene expression by Pax6 in cultured cells. Nucleic Acids Res (2001) 1.16
Differential activity of DNA methyltransferase in the life cycle of Chlamydomonas reinhardi. Proc Natl Acad Sci U S A (1981) 1.14
DNA methylation data analysis and its application to cancer research. Epigenomics (2013) 1.14
Myogenic programs of mouse muscle cell lines: expression of myosin heavy chain isoforms, MyoD1, and myogenin. J Cell Biol (1990) 1.13
Small molecules, big roles -- the chemical manipulation of stem cell fate and somatic cell reprogramming. J Cell Sci (2012) 1.12
Id3 prevents differentiation of preadipose cells. Mol Cell Biol (1997) 1.12
Finding genes in the C2C12 osteogenic pathway by k-nearest-neighbor classification of expression data. Genome Res (2002) 1.10
Induction of the metastatic phenotype in a mouse tumor model by 5-azacytidine, and characterization of an antigen associated with metastatic activity. Proc Natl Acad Sci U S A (1984) 1.10
Comparison of initial stages of muscle differentiation in rat and mouse myoblastic and mouse mesodermal stem cell lines. J Physiol (1991) 1.09
Comparison of DNA methylation patterns among mouse cell lines by restriction landmark genomic scanning. Mol Cell Biol (1994) 1.09
5-Azacytidine induces cardiac differentiation of human umbilical cord-derived mesenchymal stem cells by activating extracellular regulated kinase. Stem Cells Dev (2011) 1.07
Nuclear receptor chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) modulates mesenchymal cell commitment and differentiation. Proc Natl Acad Sci U S A (2011) 1.06
Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein. Am J Pathol (1997) 1.06
5-Azacytidine is able to induce the conversion of teratocarcinoma-derived mesenchymal cells into epithelia cells. EMBO J (1984) 1.05
An enhancer element in the house-keeping promoter for acetyl-CoA carboxylase gene. Nucleic Acids Res (1990) 1.05
Induction of prolactin-deficient variants of GH3 rat pituitary tumor cells by ethyl methanesulfonate: reversion by 5-azacytidine, a DNA methylation inhibitor. Proc Natl Acad Sci U S A (1982) 1.05
Role of Ucp1 enhancer methylation and chromatin remodelling in the control of Ucp1 expression in murine adipose tissue. Diabetologia (2010) 1.03
Effects of 5-azacytidine on methylation and expression of specific DNA sequences in C3H 10T1/2 cells. Mol Cell Biol (1984) 1.02
A new determinant of glucocorticoid sensitivity in lymphoid cell lines. J Cell Biol (1983) 1.02
DNA methylation: a phoenix rises. Proc Natl Acad Sci U S A (1993) 1.02
1,25(OH)2vitamin D3 inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cells. J Steroid Biochem Mol Biol (2010) 1.02
Epigenetic regulation of satellite cell activation during muscle regeneration. Stem Cell Res Ther (2011) 1.01
DNMT1 is regulated by ATP-citrate lyase and maintains methylation patterns during adipocyte differentiation. Mol Cell Biol (2013) 1.01
Skeletal muscle programming and re-programming. Curr Opin Genet Dev (2013) 1.00
Expression of MyoD1 coincides with terminal differentiation in determined but inducible muscle cells. EMBO J (1989) 0.98
Bone-specific expression of the alpha chain of the nascent polypeptide-associated complex, a coactivator potentiating c-Jun-mediated transcription. Mol Cell Biol (1998) 0.98
Brief demethylation step allows the conversion of adult human skin fibroblasts into insulin-secreting cells. Proc Natl Acad Sci U S A (2013) 0.97
Cellular differentiation, cytidine analogs and DNA methylation. Cell (1980) 10.15
5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science (1990) 4.80
The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res (1999) 4.74
Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res (1997) 4.65
Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med (1994) 4.34
Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res (1995) 4.28
Southern blot analysis of DNA extracted from formalin-fixed pathology specimens. Cancer Res (1986) 3.95
Increased cell division as a cause of human cancer. Cancer Res (1990) 3.38
5-methylcytosine, gene regulation, and cancer. Adv Cancer Res (1983) 3.27
Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res (1998) 2.83
Predicting survival using simple clinical variables: a case study in traumatic brain injury. J Neurol Neurosurg Psychiatry (1999) 2.83
Altering gene expression with 5-azacytidine. Cell (1985) 2.79
DNA methylation decreases in aging but not in immortal cells. Science (1983) 2.67
DNA methylation: past, present and future directions. Carcinogenesis (2000) 2.58
Cytosine methylation does not affect binding of transcription factor Sp1. Proc Natl Acad Sci U S A (1988) 2.56
The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol Cell Biol (1998) 2.53
World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition of guidelines for evaluating the efficacy of anthelmintics in ruminants (bovine, ovine, caprine) Vet Parasitol (1995) 2.48
p16 gene in uncultured tumours. Nature (1994) 2.47
Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment. Nature (1977) 2.44
The rate of hydrolytic deamination of 5-methylcytosine in double-stranded DNA. Nucleic Acids Res (1994) 2.37
Role of intracranial pressure monitoring in severely head-injured patients without signs of intracranial hypertension on initial computerized tomography. J Neurosurg (1994) 2.36
Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a. J Med Chem (1999) 2.33
Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res (2001) 2.27
Scaling community attitudes toward the mentally ill. Schizophr Bull (1981) 2.24
Parental imprinting: potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor II (Igf2) gene. Genes Dev (1992) 2.19
Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. J Natl Cancer Inst (2001) 2.13
High frequency mutagenesis by a DNA methyltransferase. Cell (1992) 2.08
Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer. J Natl Cancer Inst (1998) 2.07
Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins, and collagen by proteinases isolated from macrophages. J Exp Med (1980) 2.00
Mechanism of action of eukaryotic DNA methyltransferase. Use of 5-azacytosine-containing DNA. J Mol Biol (1982) 1.89
PAX6 methylation and ectopic expression in human tumor cells. Int J Cancer (2000) 1.87
p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol (1993) 1.85
Cell cycle-specific reactivation of an inactive X-chromosome locus by 5-azadeoxycytidine. Proc Natl Acad Sci U S A (1982) 1.84
Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer. Hum Mol Genet (2001) 1.83
Phenotypic conversion of cultured mouse embryo cells by aza pyrimidine nucleosides. Dev Biol (1978) 1.76
The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse model. J Immunol (1999) 1.75
Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer. Mol Cell Biol (1994) 1.74
A psychogeriatric survey of old people's homes. Br Med J (Clin Res Ed) (1981) 1.74
The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. Cancer Res (1998) 1.73
Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G(0)/G(1) to S phase transition in normal and tumor cells. Nucleic Acids Res (2000) 1.73
Changes in the allelic methylation patterns of c-H-ras-1, insulin and retinoblastoma genes in human development. Dev Suppl (1990) 1.73
The geographic variation of cancer incidence in Ontario. Am J Public Health (1994) 1.72
DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture. J Biol Chem (1986) 1.72
Glycoprotein, elastin, and collagen secretion by rat smooth muscle cells. Proc Natl Acad Sci U S A (1979) 1.71
Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res (1992) 1.70
Hemimethylated duplex DNAs prepared from 5-azacytidine-treated cells. Nucleic Acids Res (1981) 1.70
Inhibition of DNA methylation by chemical carcinogens in vitro. Cell (1983) 1.68
Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer. Cancer Res (1990) 1.67
Involvement of DNA methylation in human carcinogenesis. Biol Chem (1998) 1.65
Head injury in the elderly. Age Ageing (1986) 1.65
Scar formation after stereotactic vacuum-assisted core biopsy of benign breast lesions. Clin Radiol (2006) 1.60
Destruction of extracellular matrices containing glycoproteins, elastin, and collagen by metastatic human tumor cells. Cancer Res (1980) 1.59
Prescription of oxygen concentrators: adherence to published guidelines. Thorax (1989) 1.57
Percutaneous electrical nerve stimulation: an alternative to antiviral drugs for acute herpes zoster. Anesth Analg (1998) 1.51
Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res (1997) 1.51
Contiguous patches of normal human mammary epithelium derived from a single stem cell: implications for breast carcinogenesis. Cancer Res (1996) 1.51
DNA methylation differences associated with tumor tissues identified by genome scanning analysis. Genomics (1998) 1.51
HhaI and HpaII DNA methyltransferases bind DNA mismatches, methylate uracil and block DNA repair. Nucleic Acids Res (1995) 1.50
Zebularine: a new drug for epigenetic therapy. Biochem Soc Trans (2004) 1.49
Roles of cell division and gene transcription in the methylation of CpG islands. Mol Cell Biol (1999) 1.49
Fibrinolytic activity in a human fibrosarcoma cell line and evidence for the induction of plasminogen activator secretion during tumor formation. Cell (1975) 1.48
DNA methylation and cancer. Cancer Res (1986) 1.47
Assessing public health capacity to support community-based heart health promotion: the Canadian Heart Health Initiative, Ontario Project (CHHIOP). Health Educ Res (1998) 1.46
Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis (1997) 1.43
Glasgow Outcome Scale: an inter-rater reliability study. Brain Inj (1993) 1.42
The epidemiology of Ascaris suum infections in pigs in Northern Ireland, 1969-1991. Br Vet J (1994) 1.42
Change in serum hyaluronan: a simple index of short-term drug-induced changes in hepatic sinusoidal perfusion. Gastroenterology (1993) 1.41
Field evaluation of an albendazole intraruminal capsule against benzimidazole-resistant Haemonchus contortus. Vet Rec (1992) 1.40
Initial experience of intramammary prostheses in breast conservation surgery. Eur J Surg Oncol (1999) 1.38
Mutagenic and epigenetic effects of DNA methylation. Mutat Res (1997) 1.38
Ferritinaemia in leukaemia and Hodgkin's disease. Br J Cancer (1973) 1.37
Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA. Blood (2001) 1.36
p53 and treatment of bladder cancer. Nature (1997) 1.36
Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res (1994) 1.36
Variable effects of DNA-synthesis inhibitors upon DNA methylation in mammalian cells. Nucleic Acids Res (1986) 1.34
In vitro correlates of transformation in C3H/10T1/2 clone 8 mouse cells. Cancer Res (1976) 1.33
Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors. Cancer Res (1997) 1.33
Changes in phenotypic expression in embryonic and adult cells treated with 5-azacytidine. J Cell Physiol (1982) 1.32
Allele-specific methylation of the human c-Ha-ras-1 gene. Cell (1987) 1.31
Temporal acquistion of enhanced fibrinolytic activity by syrian hamster embryo cells following treatment with benzo(a)pyrene. Cancer Res (1977) 1.31
Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Br J Pharmacol (2001) 1.30
DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene. Oncogene (1997) 1.29
Critical thresholds of intracranial pressure and cerebral perfusion pressure related to age in paediatric head injury. J Neurol Neurosurg Psychiatry (2005) 1.28
DNA methylation in 5-aza-2'-deoxycytidine-resistant variants of C3H 10T1/2 C18 cells. Mol Cell Biol (1984) 1.24
Primary torsion of the omentum. Ann R Coll Surg Engl (1981) 1.24
Differential nuclear protein binding to 5-azacytosine-containing DNA as a potential mechanism for 5-aza-2'-deoxycytidine resistance. Mol Cell Biol (1987) 1.23
A new in vivo model to study invasion and metastasis of human bladder carcinoma. Cancer Res (1987) 1.23
Progressive increases in the methylation status and heterochromatinization of the myoD CpG island during oncogenic transformation. Mol Cell Biol (1994) 1.22
A longitudinal study of the health impacts of a petroleum refinery. Soc Sci Med (2000) 1.22
Evaluation of Pyrosequencing technology for the identification of clinically relevant non-dematiaceous yeasts and related species. Eur J Clin Microbiol Infect Dis (2008) 1.21
Comparison of four methods for early detection of experimental Trichinella spiralis infections in pigs. Vet Parasitol (1981) 1.21
Utility of signs and symptoms of chronic cough in predicting specific cause in children. Thorax (2006) 1.20
Global and gene-specific epigenetic patterns in human bladder cancer genomes are relatively stable in vivo and in vitro over time. Cancer Res (2001) 1.19